Do analysts recommend RKDA or CEAD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CEA Industries 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer NCRA or RKDA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nocera 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NCRA or RKDA more profitable?

Nocera has a net margin of -44.02% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Nocera's return on equity. Company Net Margins Return on Equity Return on Assets Nocera -44.02% -207.32% -47.66% Arcadia Biosciences -195.94% -113.73% -68.47%

Do analysts rate RKDA or IVP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inspire Veterinary Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer EDBL or RKDA?

Edible Garden presently has a consensus target price of $1.00, suggesting a potential upside of 400.75%. Given Edible Garden's stronger consensus rating and higher possible upside, equities research analysts clearly believe Edible Garden is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edible Garden 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer RKDA or ORIS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, RKDA or ORIS?

Oriental Rise has higher revenue and earnings than Arcadia Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arcadia Biosciences $4.86M 0.31 -$2.34M -$5.73 N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Arcadia Biosciences (RKDA) Competitors

$0.72 -0.05 (-6.54%)

As of 06/23/2026 04:00 PM Eastern

Compare

RKDA vs. CEAD, NCRA, IVP, EDBL, and ORIS

Should you buy Arcadia Biosciences stock or one of its competitors? MarketBeat compares Arcadia Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Arcadia Biosciences include CEA Industries (CEAD), Nocera (NCRA), Inspire Veterinary Partners (IVP), Edible Garden (EDBL), and Oriental Rise (ORIS). These companies are all part of the "agriculture" industry.

How does Arcadia Biosciences compare to CEA Industries?

Arcadia Biosciences (NASDAQ:RKDA) and CEA Industries (NASDAQ:CEAD) are both small-cap agriculture companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CEA Industries	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, CEA Industries had 2 more articles in the media than Arcadia Biosciences. MarketBeat recorded 2 mentions for CEA Industries and 0 mentions for Arcadia Biosciences. CEA Industries' average media sentiment score of 1.33 beat Arcadia Biosciences' score of 0.00 indicating that CEA Industries is being referred to more favorably in the news media.

Company	Overall Sentiment
Arcadia Biosciences	Neutral
CEA Industries	Positive

CEA Industries has a net margin of -118.08% compared to Arcadia Biosciences' net margin of -195.94%. CEA Industries' return on equity of -27.79% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-195.94%	-113.73%	-68.47%
CEA Industries	-118.08%	-27.79%	-24.75%

Arcadia Biosciences has higher revenue and earnings than CEA Industries. CEA Industries is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86M	0.31	-$2.34M	-$5.73	N/A
CEA Industries	$3.28M	0.51	-$2.91M	-$4.23	N/A

Arcadia Biosciences has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, CEA Industries has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market.

17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 21.6% of CEA Industries shares are owned by institutional investors. 8.2% of Arcadia Biosciences shares are owned by company insiders. Comparatively, 4.8% of CEA Industries shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

CEA Industries beats Arcadia Biosciences on 9 of the 14 factors compared between the two stocks.

How does Arcadia Biosciences compare to Nocera?

Nocera (NASDAQ:NCRA) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap agriculture companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Nocera has a net margin of -44.02% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Nocera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nocera	-44.02%	-207.32%	-47.66%
Arcadia Biosciences	-195.94%	-113.73%	-68.47%

1.3% of Nocera shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 5.2% of Nocera shares are owned by company insiders. Comparatively, 8.2% of Arcadia Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nocera	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Arcadia Biosciences has lower revenue, but higher earnings than Nocera. Nocera is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nocera	$13.63M	0.12	-$2.84M	-$0.22	N/A
Arcadia Biosciences	$4.86M	0.31	-$2.34M	-$5.73	N/A

In the previous week, Nocera had 1 more articles in the media than Arcadia Biosciences. MarketBeat recorded 1 mentions for Nocera and 0 mentions for Arcadia Biosciences. Nocera's average media sentiment score of 0.00 equaled Arcadia Biosciences'average media sentiment score.

Company	Overall Sentiment
Nocera	Neutral
Arcadia Biosciences	Neutral

Nocera has a beta of 1.72, meaning that its share price is 72% more volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

Summary

Nocera and Arcadia Biosciences tied by winning 6 of the 12 factors compared between the two stocks.

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Arcadia Biosciences (NASDAQ:RKDA) and Inspire Veterinary Partners (NASDAQ:IVP) are both small-cap agriculture companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Inspire Veterinary Partners has a net margin of -76.75% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Inspire Veterinary Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-195.94%	-113.73%	-68.47%
Inspire Veterinary Partners	-76.75%	-520.34%	-55.79%

17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 4.8% of Inspire Veterinary Partners shares are held by institutional investors. 8.2% of Arcadia Biosciences shares are held by company insiders. Comparatively, 6.4% of Inspire Veterinary Partners shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inspire Veterinary Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Arcadia Biosciences has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, Inspire Veterinary Partners has a beta of -0.49, suggesting that its stock price is 149% less volatile than the broader market.

Arcadia Biosciences has higher earnings, but lower revenue than Inspire Veterinary Partners. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Inspire Veterinary Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86M	0.31	-$2.34M	-$5.73	N/A
Inspire Veterinary Partners	$15.56M	0.09	-$14.26M	-$2.20	N/A

In the previous week, Arcadia Biosciences' average media sentiment score of 0.00 equaled Inspire Veterinary Partners'average media sentiment score.

Company	Overall Sentiment
Arcadia Biosciences	Neutral
Inspire Veterinary Partners	Neutral

Summary

Arcadia Biosciences beats Inspire Veterinary Partners on 6 of the 11 factors compared between the two stocks.

How does Arcadia Biosciences compare to Edible Garden?

Edible Garden (NASDAQ:EDBL) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap agriculture companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

13.0% of Edible Garden shares are held by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are held by institutional investors. 0.8% of Edible Garden shares are held by company insiders. Comparatively, 8.2% of Arcadia Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Arcadia Biosciences has lower revenue, but higher earnings than Edible Garden. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Edible Garden, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edible Garden	$12.81M	0.09	-$17.33M	-$109.66	N/A
Arcadia Biosciences	$4.86M	0.31	-$2.34M	-$5.73	N/A

Edible Garden has a net margin of -131.59% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Edible Garden's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edible Garden	-131.59%	-1,078.80%	-88.36%
Arcadia Biosciences	-195.94%	-113.73%	-68.47%

Edible Garden has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market.

In the previous week, Edible Garden had 7 more articles in the media than Arcadia Biosciences. MarketBeat recorded 7 mentions for Edible Garden and 0 mentions for Arcadia Biosciences. Edible Garden's average media sentiment score of 0.98 beat Arcadia Biosciences' score of 0.00 indicating that Edible Garden is being referred to more favorably in the media.

Company	Overall Sentiment
Edible Garden	Positive
Arcadia Biosciences	Neutral

Edible Garden presently has a consensus target price of $1.00, suggesting a potential upside of 400.75%. Given Edible Garden's stronger consensus rating and higher possible upside, equities research analysts clearly believe Edible Garden is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edible Garden	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Edible Garden beats Arcadia Biosciences on 9 of the 16 factors compared between the two stocks.

How does Arcadia Biosciences compare to Oriental Rise?

Arcadia Biosciences (NASDAQ:RKDA) and Oriental Rise (NASDAQ:ORIS) are both small-cap agriculture companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

Oriental Rise has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -195.94%. Oriental Rise's return on equity of 0.00% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-195.94%	-113.73%	-68.47%
Oriental Rise	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Oriental Rise has higher revenue and earnings than Arcadia Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86M	0.31	-$2.34M	-$5.73	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

In the previous week, Oriental Rise had 1 more articles in the media than Arcadia Biosciences. MarketBeat recorded 1 mentions for Oriental Rise and 0 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.00 equaled Oriental Rise'saverage media sentiment score.

Company	Overall Sentiment
Arcadia Biosciences	Neutral
Oriental Rise	Neutral

17.7% of Arcadia Biosciences shares are held by institutional investors. 8.2% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Arcadia Biosciences has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market.

Summary

Oriental Rise beats Arcadia Biosciences on 7 of the 10 factors compared between the two stocks.

Get Arcadia Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RKDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RKDA vs. The Competition

Export

Metric	Arcadia Biosciences	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.59M	$3.45B	$6.44B	$12.30B
Dividend Yield	N/A	2.30%	2.69%	5.83%
P/E Ratio	-0.13	19.75	24.65	23.99
Price / Sales	0.31	331.95	535.11	118.14
Price / Cash	0.60	128.56	44.82	54.51
Price / Book	0.30	8.29	10.70	6.50
Net Income	-$2.34M	$23.85M	$3.56B	$336.88M
7 Day Performance	-13.80%	2.87%	0.94%	-0.16%
1 Month Performance	-21.52%	2.19%	0.35%	0.76%
1 Year Performance	-83.41%	55.48%	29.67%	28.49%

Arcadia Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RKDA Arcadia Biosciences	0.3132 of 5 stars	$0.72 -6.5%	N/A	-82.8%	$1.59M	$4.86M	N/A	60	Gap Down
CEAD CEA Industries	N/A	$2.48 +11.7%	N/A	-71.9%	$1.99M	$3.28M	N/A	30	News Coverage Gap Up High Trading Volume
NCRA Nocera	0.4639 of 5 stars	$0.12 -2.5%	N/A	-89.2%	$1.78M	$13.63M	N/A	10	Gap Down
IVP Inspire Veterinary Partners	0.0515 of 5 stars	$0.03 flat	N/A	N/A	$1.41M	$15.56M	N/A	156
EDBL Edible Garden	3.8186 of 5 stars	$0.22 -0.9%	$1.00 +358.7%	-99.3%	$1.20M	$12.81M	N/A	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RKDA) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arcadia Biosciences (RKDA) Competitors

RKDA vs. CEAD, NCRA, IVP, EDBL, and ORIS

How does Arcadia Biosciences compare to CEA Industries?

Summary

How does Arcadia Biosciences compare to Nocera?

Summary

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Summary

How does Arcadia Biosciences compare to Edible Garden?

Summary

How does Arcadia Biosciences compare to Oriental Rise?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKDA vs. The Competition

Arcadia Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arcadia Biosciences (RKDA) Competitors

RKDA vs. CEAD, NCRA, IVP, EDBL, and ORIS

How does Arcadia Biosciences compare to CEA Industries?

Do analysts recommend RKDA or CEAD?

Does the media prefer RKDA or CEAD?

Is RKDA or CEAD more profitable?

Which has preferable earnings & valuation, RKDA or CEAD?

Which has more volatility & risk, RKDA or CEAD?

Do insiders and institutionals hold more shares of RKDA or CEAD?

Summary

How does Arcadia Biosciences compare to Nocera?

Is NCRA or RKDA more profitable?

Do institutionals & insiders believe in NCRA or RKDA?

Do analysts prefer NCRA or RKDA?

Which has higher earnings and valuation, NCRA or RKDA?

Does the media refer more to NCRA or RKDA?

Which has more risk and volatility, NCRA or RKDA?

Summary

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Is RKDA or IVP more profitable?

Do insiders & institutionals believe in RKDA or IVP?

Do analysts rate RKDA or IVP?

Which has more risk & volatility, RKDA or IVP?

Which has higher earnings & valuation, RKDA or IVP?

Does the media prefer RKDA or IVP?

Summary

How does Arcadia Biosciences compare to Edible Garden?

Do insiders and institutionals hold more shares of EDBL or RKDA?

Which has better earnings and valuation, EDBL or RKDA?

Is EDBL or RKDA more profitable?

Which has more risk & volatility, EDBL or RKDA?

Does the media favor EDBL or RKDA?

Do analysts prefer EDBL or RKDA?

Summary

How does Arcadia Biosciences compare to Oriental Rise?

Is RKDA or ORIS more profitable?

Do analysts prefer RKDA or ORIS?

Which has stronger earnings and valuation, RKDA or ORIS?

Does the media prefer RKDA or ORIS?

Do insiders & institutionals have more ownership in RKDA or ORIS?

Which has more volatility & risk, RKDA or ORIS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKDA vs. The Competition

Arcadia Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools